Skip to main content
Premium Trial:

Request an Annual Quote

Richard Taylor Joins Vermillion

Premium
Vermillion appointed Richard Taylor senior finance consultant and interim chief financial officer last month.
 
He takes over as interim CFO from Qun Zhou, who had held the post since Nov. 1, 2007. The consulting agreement between Taylor and Vermillion is for 90 days and may be extended upon mutual agreement.
 
Prior to joining Vermillion, Taylor was head of finance for US operations at Progen Pharmaceuticals. Between 2001 and February of 2008, Taylor was vice president of finance and administration at Cellgate before it was acquired by Progen.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.